ArticleScientific reports2024

Structure-based development of 3,5-dihydroxybenzoyl-hydrazineylidene as tyrosinase inhibitor; in vitro and in silico study.

Azzam Bagheri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.